102 On the other hand, various groups are advocating with the incorporation of novel markers, like a elaborate karyotype55 or epigenetic subsets, 27,28 into clinical apply. All of these novel prognostic and/or predictive designs will must be validated in cohorts of individuals addressed with focused brokers.It is necessary to look at the movement c